FDA Compiles List of Acceptable Valsartan and ARB Class Medications – APhA submits compounding comments to FDA. – (866) 348-2889.
Officials with the FDA have identified 40 angiotensin II receptor blockers (ARBs) that do not contain any known nitrosamine impurities. The announcement follows months of investigating impurities found in ARBs.
“Our goal is for this information to help health care providers as they consider acceptable treatment options for their patients,” said FDA Commissioner Scott Gottlieb, MD, and Janet Woodcock, MD, director of the Center for Drug Evaluation and Research, in a joint prepared statement. “We’ll continue to update this list of nitrosamine-free ARBs as we become aware of additional information and as we progress in our assessments of other ARB medications.”